Search filters

List of works by Stanley C Jordan

A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

scientific article published on 25 May 2015

A Phase I/II, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

scientific article published on 10 April 2018

A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients.

scientific article published in October 2005

A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.

scientific article published in February 2015

ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation? ⬇️

scientific article published on November 1, 2010

Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy

scientific article published in September 2008

Achieving incompatible transplantation through desensitization: current perspectives and future directions

scientific article published on January 2015

Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients

scientific article

Adenovirus mediated IL-10 gene transfer to the airway of the rat lung for prevention of lung allograft rejection

article

Advances in diagnosing and managing antibody-mediated rejection

scientific article published on 14 January 2010

Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System

scientific article published on 28 March 2019

Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation

scientific article published on July 2003

Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients ⬇️

scientific article published on December 27, 2010

Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization

scientific article published on 10 June 2008

Anti-CD3ϵ induces splenic B220 lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization ⬇️

scientific article published on April 24, 2012

Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis

scientific article published on 13 December 2006

Anti-glomerular basement membrane disease in an HIV-infected patient

scientific article

Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization

scientific article published on 01 December 2014

Antibody Testing Strategies for Deceased Donor Kidney Transplantation After Immunomodulatory Therapy ⬇️

scientific article published on July 15, 2011

Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes

scientific article published on 15 December 2020

B-cell immunotherapeutics: emerging roles in solid organ transplantation

scientific article published on August 2011

Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients

scientific article published on 01 August 2014

Cell-Free DNA and Active Rejection in Kidney Allografts.

scientific article published on 9 March 2017

Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levels

scientific article published on 21 May 2010

Cellular immune responses to cytomegalovirus in renal transplant recipients

scientific article published in January 2005

Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes

scientific article published on 30 March 2020

Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation

scientific article published on 01 December 2019

Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.

scientific article published on 15 February 2017

Clinical and Public Policy Implications of Pre-Formed DSA and Transplant Outcomes

scientific article published on 18 June 2019

Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies

scientific article published in December 2017

Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients.

scientific article

Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients.

scientific article published in July 2005

Combined Heart and Kidney Transplantation: Clinical Experience in 100 Consecutive Patients

scientific article published on 01 February 2019

Combined Lung-Kidney Transplantation: An Analysis of the UNOS/OPTN Database

scientific article published on October 2015

Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia

scientific article published on 23 June 2020

Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols

scientific article published in July 2004

Current approaches to treatment of antibody-mediated rejection

scientific article

Defining the Benefits of Desensitization Therapy ⬇️

scientific article published on March 27, 2013

Delayed Graft Function and Acute Rejection Following HLA-Incompatible Living Donor Kidney Transplantation

scientific article published on 28 December 2020

Desensitization Offers Hope to Highly HLA-Sensitized Patients for a Longer Life Expectancy After Incompatible Kidney Transplant ⬇️

scientific article published on March 30, 2012

Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation.

scientific article

Desensitization: Overcoming the Immunologic Barriers to Transplantation

scientific article

Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies

scientific article published on 16 January 2017

Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone

scientific article published on 15 July 2020

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients

Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants

scientific article published on 20 November 2020

Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches

scientific article

Dual kidneys from marginal adult donors as a source for cadaveric renal transplantation in the United States

scientific article published on April 2003

Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients

scientific article published on 29 March 2019

Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome ⬇️

scientific article published on August 26, 2010

Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab ⬇️

scientific article published on March 27, 2013

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

scientific article

Evolving concepts in desensitization

Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates

scientific article published on April 1, 2012

Fabry disease in a renal allograft

scientific article

Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization

scientific article published on 01 July 2015

Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection

scientific article published on 13 November 2014

Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab

scientific article published on 28 March 2014

Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study

scientific article published on 21 August 2017

Ibrutinib suppresses alloantibody responses in a mouse model of allosensitization

scientific article published on 23 September 2017

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation

scientific article

Imlifidase Inhibits HLA Antibody-Mediated NK Cell Activation and Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) In Vitro

scientific article published on 21 October 2019

Imlifidase desensitization in crossmatch-positive, highly-sensitized kidney transplant recipients: Results of an international phase 2 trial (Highdes)

scientific article published on 21 October 2020

Immunoglobulin G-Degrading Enzyme of Streptococcus pyogenes (IdeS), Desensitization, and the Kidney Allocation System: Complementary Approaches to Increase Transplantation in Highly HLA Sensitized Patients

scientific article published on 09 March 2018

Immunologic and Infectious Complications in Highly Sensitized Patients Post-Kidney Transplantation

scientific article published on January 2015

Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab ⬇️

scientific article published on November 28, 2010

Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction

scientific article published in October 2004

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.

scientific article published on 06 February 2017

Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection

scientific article published on 01 April 2020

Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999.

scientific article published on January 2002

Implications of Fc Neonatal Receptor (FcRn) Manipulations for Transplant Immunotherapeutics

scientific article published on 01 January 2020

In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction

scientific article published on 6 July 2010

Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin ⬇️

scientific article published on December 1, 2011

Interleukin 6: An Important Mediator of Allograft Injury

scientific article published on 30 March 2020

Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade

scientific article

Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization

scientific article published on 26 November 2009

Intravenous Immunoglobulin Significantly Reduces Exposure of Concomitantly Administered Anti-C5 Monoclonal Antibody Tesidolumab

scientific article published on 16 April 2020

Intravenous immunoglobulin a natural regulator of immunity and inflammation

scientific article published on July 2009

Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature

scientific article published on July 2008

Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.

scientific article

Kidney transplantation in highly sensitized patients

scientific article published on May 2015

Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?

scientific article published on 26 November 2019

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

scientific article

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions

scientific article

Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction

scientific article published on 5 May 2010

National conference to assess antibody-mediated rejection in solid organ transplantation

scientific article published in July 2004

Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection

scientific article published on 01 February 2019

Novel immunotherapeutic approaches to improve rates and outcomes of transplantation in sensitized renal allograft recipients

scientific article published on March 1, 2012

Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy

scientific article published on 03 July 2020

Outcome of management strategies for BK virus replication in pediatric renal transplant recipients

scientific article published in March 2008

Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in HLA Sensitized Kidney Transplant Recipients

scientific article published on 19 September 2019

Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection

scientific article published on 27 May 2017

Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab

scientific article published on April 2014

Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells

scientific article published on 01 February 2003

Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection

scientific article

Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation

scientific article

Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy

scientific article published on 23 August 2018

Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy

scientific article published on 2 November 2007

Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group

scientific article published on 08 January 2020

Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents

scientific article published on 01 February 2014

Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation ⬇️

scientific article published on May 1, 2011

Reply to authors

scientific article published on 04 September 2020

Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy

scientific article published on 25 November 2010

Risk factors associated with the development of histocompatibility leukocyte antigen sensitization

scientific article published on June 2016

Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients

scientific article published on 19 September 2017

Rituximab and intravenous immune globulin for desensitization during renal transplantation

scientific article published in July 2008

Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients

scientific article published on 5 August 2016

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience

scientific article published on 26 April 2006

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant

scientific article published on 23 July 2019

Significant Reduction of ATP Production in PHA-Activated CD4+ Cells in 1-Day-Old Blood from Transplant Patients ⬇️

scientific article published on December 27, 2012

Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab

scientific article published on 16 August 2016

Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials Process

Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report

scientific article published on 07 June 2020

Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.

scientific article published on March 2016

The authors' reply

scientific article published on 01 July 2014

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure

scientific article published on 17 April 2012

The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection

scientific article published on 01 June 2020

Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts

scientific article published on January 2009

Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients

scientific article published on 31 October 2008

Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

scientific article published on 16 December 2019

Tocilizumab (Anti-IL-6R) Suppressed TNFα Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity

scientific article published on 16 February 2017

Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies

scientific article published on 01 December 2020

Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation

scientific article published on 08 August 2020

Transplantation: Donor-specific HLA antibodies and renal allograft failure

scientific article published on 12 February 2013

Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction

scientific article published in August 2002

Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence

scientific article

Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

scientific article published on 16 October 2007

Update on C1 Esterase Inhibitor in Human Solid Organ Transplantation

scientific article published on 01 September 2019

Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience.

scientific article published in January 2003

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

scientific article published in May 2010

Paulina is supported by:

About Paulina

Help